Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis

Kang Wang1, Chen Wang2, Hua Zhu2

  • 1Department of Orthopedics, Children's Hospital of Hebei Province, No. 133 Jianhua South Street, Shijiazhuang City, Hebei Province, China. wangkang5@126.com.

PubMed
Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infection in children with acute osteomyelitis (AO) is associated with higher C-reactive protein (CRP) and white blood cell (WBC) counts. Early identification of MRSA in pediatric AO cases can be aided by specific clinical and laboratory markers.

Area of Science:

  • Pediatric infectious diseases
  • Clinical microbiology
  • Orthopedic surgery

Background:

  • Acute osteomyelitis (AO) is a bone infection that can affect children.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of healthcare-associated infections.
  • Early identification of MRSA in pediatric AO is crucial for effective treatment.

Purpose of the Study:

  • Identify risk factors for MRSA infection in children with AO.
  • Characterize laboratory findings in MRSA-infected children with AO.
  • Improve early targeted therapeutic interventions for MRSA in pediatric AO.

Main Methods:

  • Retrospective analysis of 123 children with AO.
  • Measurement of WBC, CRP, ESR, and platelet counts upon admission.
  • Categorization into non-MRSA (n=73) and MRSA (n=50) groups.

Main Results:

  • MRSA group had higher average age and markedly elevated CRP levels on admission.
  • Suppurative arthritis incidence was lower in the MRSA group.
  • Elevated WBC and CRP levels persisted in the MRSA group after three days of empirical therapy.

Conclusions:

  • A CRP level > 73.23 µg/mL upon admission may indicate MRSA infection in pediatric AO.
  • Specific markers (WBC > 10.95×10^9/L, CRP > 49.56 µg/mL, age > 3.5 years, absence of suppurative arthritis) suggest heightened MRSA risk after 3 days of therapy.